Edesa Biotech Extends Dermatitis Study to Canada

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Edesa Biotech Extends Dermatitis Study to Canada
(NASDAQ: EDSA) Delayed: 6.52 +2.91 (80.61%)
Previous Close $3.61    52 Week High $ 
Open $3.64    52 Week Low $ 
Day High $7.43    P/E N/A 
Day Low $3.55    EPS $ 
Volume 32,147,838